In vitro genetic analysis of the RNA binding site of vigilin, a multi- KH-domain protein

Molecular and Cellular Biology

Volumn 18, Issue 7, 1998, Pages 3991-4003

  Kanamori, Hiroshi ^a   Dodson, Robin E ^a   Shapiro, David J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VIGILIN;

ARTICLE; GENE DELETION; GENETIC SELECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN RNA BINDING; RNA SEQUENCE; SEQUENCE HOMOLOGY;

EID: 0031862144     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.7.3991     Document Type: Article

References (70)

1. Arning, S., P. Grüter, G. Bilbe, and A. Krämer. 1996. Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA. RNA 2:794-810.
2. Ashley, C. T., Jr., K. D. Wilkinson, D. Reines, and S. T. Warren. 1993. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262:563-566.
3. Bartel, D. P., M. L. Zapp, M. R. Green, and J. W. Szostak. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67:529-536.
4. Battiste, J. L., R. Tan, A. D. Frankel, and J. R. Williamson. 1994. Binding of an HIV Rev peptide to Rev responsive element RNA induces formation of purine-purine base pairs. Biochemistry 33:2741-2747.
5. Beelman, C. A., and R. Parker. 1995. Degradation of mRNA in eukaryotes. Cell 81:179-183.
6. Belasco, J., and G. Brawerman. 1993. Control of messenger RNA stability. Academic Press Inc., San Diego, Calif.
7. Binkley, J., P. Allen, D. M. Brown, L. Green, C. Tuerk, and L. Gold. 1995. RNA ligands to human nerve growth factor. Nucleic Acids Res. 23:3198-3205.
8. Blackwell, T. K., and H. Weintraub. 1990. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 250:1104-1110.
9. Blume, J. E., and D. J. Shapiro. 1989. Ribosome loading, but not protein synthesis, is required for estrogen stabilization of Xenopus laevis vitellogenin mRNA. Nucleic Acids Res. 17:9003-9014.
10. Brock, M. L., and D. J. Shapiro. 1983. Estrogen stabilizes vitellogenin mRNA against cytoplasmic degradation. Cell 34:207-214.
11. Brown, D., J. Brown, C. Kang, L. Gold, and P. Allen. 1997. Single-stranded RNA recognition by the bacteriophage T4 translational repressor, regA. J. Biol. Chem. 272:14969-14974.
12. Buckanovich, R. J., and R. B. Darnell. 1997. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 17:3194-3201.
13. Buckanovich, R. J., Y. Y. Yang, and R. B. Darnell. 1996. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J. Neurosci. 16:1114-1122.
14. Burd, C. G., and G. Dreyfuss. 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science 265:615-621.
15. Burd, C. G., and G. Dreyfuss. 1994. RNA binding specificity of hnRNP A1: significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J. 13:1197-1204.
16. Cadwell, R. C., and G. F. Joyce. 1992. Randomization of genes by PCR mutagenesis. PCR Methods Appl. 2:28-33.
17. Casey, J. L., D. M. Koeller, V. C. Ramin, R. D. Klausner, and J. B. Harford. 1989. Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA. EMBO J. 8:3693-3699.
18. Chagnovich, D., B. E. Fayos, and S. L. Conn. 1996. Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma. J. Biol. Chem. 271:33587-33591.
19. Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
20. Chiang, C. M., and R. G. Roeder. 1993. Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution. Peptide Res. 6:62-64.
21. Dejgaard, K., and H. Leffers. 1996. Characterisation of the nucleic-acid-binding activity of KH domains. Different properties of different domains. Eur. J. Biochem. 241:425-431.
22. DeMaria, C. T., and G. Brewer. 1996. AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. J. Biol. Chem. 271: 12179-12184.
23. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.
24. Dodson, R. E., M. R. Acena, and D. J. Shapiro. 1995. Tissue distribution, hormone regulation and evidence for a human homologue of the estrogen-inducible Xenopus laevis vitellogenin mRNA binding protein. J. Steroid Biochem. Mol. Biol. 52:505-515.
25. Dodson, R. E., and D. J. Shapiro. 1994. An estrogen-inducible protein binds specifically to a sequence in the 3′ untranslated region of estrogen-stabilized vitellogenin mRNA. Mol. Cell. Biol. 14:3130-3138.
26. Dodson, R. E., and D. J. Shapiro. 1997. Vigilin, a ubiquitous protein with 14 K homology domains, is the estrogen-inducible vitellogenin mRNA 3′-untranslated region-binding protein. J. Biol. Chem. 272:12249-12252.
27. Gibson, T. J., J. D. Thompson, and J. Heringa. 1993. The KH domain occurs in a diverse set of RNA-binding proteins that include the antiterminator NusA and is probably involved in binding to nucleic acid. FEBS Lett. 324: 361-366.
28. Gold, L., B. Polisky, O. Uhlenbeck, and M. Yarus. 1995. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64:763-797.
29. Görlach, M., C. G. Burd, and G. Dreyfuss. 1994. The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins. J. Biol. Chem. 269:23074-23078.
30. Green, S., P. Walter, V. Kumar, A. Krust, J. M. Bornert, P. Argos, and P. Chambon. 1986. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320:134-139.
31. Heinrichs, V., and B. S. Baker. 1995. The Drosophila SR protein RBP1 contributes to the regulation of doublesex alternative splicing by recognizing RBP1 RNA target sequences. EMBO J. 14:3987-1000.
32. Jellinek, D., C. K. Lynott, D. B. Rifkin, and N. Janjic. 1993. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc. Natl. Acad. Sci. USA 90:11227-11231.
33. Kjems, J., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1992. Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11:1119-1129.
34. Kruse, C., A. Grünweiler, H. Notbohm, S. Kügler, W. G. Purschke, and P. K. Müller. 1996. Evidence for a novel cytoplasmic tRNA-protein complex containing the KH-multidomain protein vigilin. Biochem. J. 320:247-252.
35. Kügler, S., A. Grünweller, C. Probst, M. Klinger, P. K. Müller, and C. Kruse. 1996. Vigilin contains a functional nuclear localisation sequence and is present in both the cytoplasm and the nucleus. FEBS Lett. 382:330-334.
36. Kühn, L. C., A. McClelland, and F. H. Ruddle. 1984. Gene transfer, expression, and molecular cloning of the human transferrin receptor gene. Cell 37:95-103.
37. Lacadena, J., A. Martínez del Pozo, J. L. Barbero, J. M. Mancheño, M. Gasset, M. Oñaderra, C. López-Otín, S. Ortega, J. García, and J. G. Gavilanes. 1994. Overproduction and purification of biologically active native fungal alpha-sarcin in Escherichia coli. Gene 142:147-151.
38. Leffers, H., K. Dejgaard, and J. E. Celis. 1995. Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains. Eur. J. Biochem. 230:447-453.
39. Levine, T. D., F. Gao, P. H. King, L. G. Andrews, and J. D. Keene. 1993. Hel-N1: an autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 13:3494-3504.
40. Liu, M. Y., H. Yang, and T. Romeo. 1995. The product of the pleiotropic Escherichia coli gene csrA modulates glycogen biosynthesis via effects on mRNA stability. J. Bacteriol. 177:2663-2672.
41. Lorincz, M. A., J. A. Holt, and G. L. Greene. 1985. Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas. J. Clin. Endocrinol. Metab. 61:412-417.
42. Matunis, M. J., W. M. Michael, and G. Dreyfuss. 1992. Characterization and primary structure of the poly(C)-binding heterogeneous nuclear ribonucleoprotein complex K protein. Mol. Cell. Biol. 12:164-171.
43. McKnight, G. L., J. Reasoner, T. Gilbert, K. O. Sundquist, B. Hokland, P. A. McKernan, J. Champagne, C. J. Johnson, M. C. Bailey, R. Holly, P. J. O'Hara, and J. F. Oram. 1992. Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. J. Biol. Chem. 267:12131-12141.
44. Müllner, E. W., B. Neupert, and L. C. Kühn. 1989. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell 58:373-382.
45. Musco, G., G. Stier, C. Joseph, M. A. Castiglione Morelli, M. Nilges, T. J. Gibson, and A. Pastore. 1996. Three-dimensional structure and stability of the KH domain: molecular insights into the fragile X syndrome. Cell 85: 237-245.
46. Nandabalan, K., and G. S. Roeder. 1995. Binding of a cell-type-specific RNA splicing factor to its target regulatory sequence. Mol. Cell. Biol. 15:1953-1960.
47. Neu-Yilik, G., H. Zorbas, T. R. Gloe, H. M. Raabe, T. A. Hopp-Christensen, and P. K. Müller. 1993. Vigilin is a cytoplasmic protein. A study on its expression in primary cells and in established cell lines of different species. Eur. J. Biochem. 213:727-736.
48. Nielsen, D. A., and D. J. Shapiro. 1990. Estradiol and estrogen receptor-dependent stabilization of a minivitellogenin mRNA lacking 5,100 nucleotides of coding sequence. Mol. Cell. Biol. 10:371-376.
49. Plenz, G., Y. Gan, H. M. Raabe, and P. K. Müller. 1993. Expression of vigilin in chicken cartilage and bone. Cell Tissue Res 273:381-389.
50. Plenz, G., S. Kügler, S. Schnittger, H. Rieder, C. Fonatsch, and P. K. Müller. 1994. The human vigilin gene: identification, chromosomal localization and expression pattern. Hum. Genet. 93:575-582.
51. Ree, A. H., H. K. Knutsen, B. F. Landmark, W. Eskild, and V. Hansson. 1992. Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule? Endocrinology 131:1810-1814.
52. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
53. Saceda, M., C. Knabbe, R. B. Dickson, M. E. Lippman, D. Bronzert, R. K. Lindsey, M. M. Gottardis, and M. B. Martin. 1991. Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. J. Biol. Chem. 266:17809-17814.
54. Schmidt, C., B. Henkel, E. Poschl, H. Zorbas, W. G. Purschke, T. R. Gloe, and P. K. Müller. 1992. Complete cDNA sequence of chicken vigilin, a novel protein with amplified and evolutionary conserved domains. Eur. J. Biochem. 206:625-634.
55. Siebel, C. W., A. Admon, and D. C. Rio. 1995. Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing. Genes Dev. 9:269-283.
56. Singh, R., J. Valcarcel, and M. R. Green. 1995. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268:1173-1176.
57. Siomi, H., M. Choi, M. C. Siomi, R. L. Nussbaum, and G. Dreyfuss. 1994. Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77:33-39.
58. Siomi, H., M. J. Matunis, W. M. Michael, and G. Dreyfuss. 1993. The pre-mRNA binding K protein contains a novel evolutionarily conserved motif. Nucleic Acids Res. 21:1193-1198.
59. Siomi, M. C., H. Siomi, W. H. Sauer, S. Srinivasan, R. L. Nussbaum, and G. Dreyfuss. 1995. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J. 14:2401-2408.
60. Siomi, M. C., Y. Zhang, H. Siomi, and G. Dreyfuss. 1996. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol. Cell. Biol. 16:3825-3832.
61. Swanson, M. S., and G. Dreyfuss. 1988. Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol. Cell. Biol. 8:2237-2241.
62. Tacke, R., and J. L. Manley. 1995. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14:3540-3551.
63. Takagaki, Y., and J. L. Manley. 1997. RNA recognition by the human polyadenylation factor CstF. Mol. Cell. Biol. 17:3907-3914.
64. Tsai, D. E., D. S. Harper, and J. D. Keene. 1991. U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts. Nucleic Acids Res. 19:4931-4936.
65. Tuerk, C., S. Eddy, D. Parma, and L. Gold. 1990. Autogenous translational operator recognized by bacteriophage T4 DNA polymerase. J. Mol. Biol. 213:749-761.
66. Wang, J., Z. Dong, and L. R. Bell. 1997. Sex-lethal interactions with protein and RNA. Roles of glycine-rich and RNA binding domains. J. Biol. Chem. 272:22227-22235.
67. Wang, L. L., S. Richard, and A. S. Shaw. 1995. P62 association with RNA is regulated by tyrosine phosphorylation. J. Biol. Chem. 270:2010-2013.
68. Wang, X., and S. A. Liebhaber. 1996. Complementary change in cis determinants and trans factors in the evolution of an mRNP stability complex. EMBO J. 15:5040-5051.
69. Wintersberger, U., C. Kühne, and A. Karwan. 1995. Scp160p, a new yeast protein associated with the nuclear membrane and the endoplasmic reticulum, is necessary for maintenance of exact ploidy. Yeast 11:929-944.
70. Zuker, M. 1989. Computer prediction of RNA structure. Methods Enzymol. 180:262-288.